Results 211 to 220 of about 5,331,742 (248)

The Natural Flavonoid Pectolinarigenin Targets On-Canonical NF-κB Pathway to Inhibit Esophageal Squamous Cell Carcinoma and Enhances Paclitaxel Efficacy. [PDF]

Drug Dev Res
Li E, Wang L, Hu W, Zhu M, Shi Z, Xu P, Fan T, Hou G.   +7 more
europepmc   +1 more source

Essential Updates 2024–2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization

Annals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1368-1381, September 2026.
This review summarizes key advances from 2024 to 2025 that are reshaping esophageal cancer surgery toward a strategy‐oriented, personalized paradigm through the integration of immunotherapy, population aging, and intelligent technologies. Adjuvant nivolumab after neoadjuvant chemoradiotherapy remains the only perioperative approach with durable benefit,
Shuichiro Oya, Koichi Yagi, Yoshifumi Baba   +2 more
wiley   +1 more source

miR-335-3p acts as a tumor suppressor in esophageal squamous cell carcinoma and predicts favorable prognosis. [PDF]

Hereditas
He M, Lu S, Yang F, Xu J, Zhu R.
europepmc   +1 more source

Potential Survival Benefit of Neoadjuvant Docetaxel, Cisplatin and 5‐Fluorouracil Therapy in Patients With Esophageal Squamous Cell Carcinoma With Multiple Lymph Node Metastases: A Single‐Institute Propensity Score Analysis

Annals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1496-1506, September 2026.
Although neoadjuvant chemotherapy with fluorouracil, cisplatin, and docetaxel (NAC‐DCF) is the current standard neoadjuvant regimen for esophageal squamous cell carcinoma, its substantial toxicity underscores the need to identify patients who derive the greatest benefit.
Eiji Higaki, Tetsuya Abe, Hironori Fujieda, Shigenori Kadowaki, Tsutomu Tanaka, Masahiro Tajika, Koji Komori, Seiji Ito, Isao Oze, Kei Muro   +9 more
wiley   +1 more source

Applications of Artificial Intelligence in the Endoscopic Detection and Characterization of Early Esophageal Squamous Cell Carcinoma: A Scoping Review. [PDF]

Cancers (Basel)
Rodríguez-Velásquez F, Montoya-Durán A, Bonilla N, Echeverri-Hoyos J, Echeverri-Franco JA, Tuta-Quintero E.   +5 more
europepmc   +1 more source

Clinical Significance of PD‐L1 and HLA Expression in Esophageal Squamous Cell Carcinoma in Response to Immunotherapy

Annals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1507-1517, September 2026.
This study evaluated immune‐related biomarkers in esophageal squamous cell carcinoma treated with immune checkpoint inhibitors after postoperative recurrence. PD‐L1 expression in tumor‐associated macrophages and tumor cells, together with HLA class I downregulation and HLA‐DR expression, were associated with favorable responses to immunotherapy.
Kosuke Kanemitsu, Yoshiyuki Tagayasu, Yoshihiro Komohara, Cheng Pan, Rin Yamada, Yukio Fujiwara, Kazuto Harada, Keisuke Kosumi, Yoshifumi Baba, Masaaki Iwatsuki   +9 more
wiley   +1 more source

Metformin Use and Development of Esophageal Squamous Cell Carcinoma.

JAMA Netw Open
Xie SH, Santoni G, Birgisson H, von Euler-Chelpin M, Kauppila JH, Ness-Jensen E, Lagergren J.   +6 more
europepmc   +1 more source

Sequential multimodal endoscopic therapy for recurrent extensive superficial basaloid esophageal squamous cell carcinoma with a 24-month follow-up. [PDF]

Endoscopy
Huang J, Wu W, Zhang X, Chang Y.
europepmc   +1 more source

Systematic Review and Meta‐Analysis on the Efficacy and Safety of Salvage Esophagectomy for T4 Esophageal Squamous Cell Carcinoma

Annals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1441-1449, September 2026.
This meta‐analysis of 208 cases shows that salvage esophagectomy for cT4 esophageal squamous cell carcinoma achieves a 72% R0 resection rate, offering a curative pathway for selected patients. However, it remains a high‐risk procedure with an 18% anastomotic leak rate and 30% major complications (Clavien–Dindo ≥ III).
Makoto Sakai, Kengo Kuriyama, Kazue Nagai, Ken Shirabe, Hiroshi Saeki   +4 more
wiley   +1 more source

Prognostic value and potential upstream regulator of Schwann cells in esophageal squamous cell carcinoma. [PDF]

Transl Cancer Res
Lei Y, Zhang X, Hou W, Zhang X, Zhou Z, Liu Q, Zhang J, Liu F, Wang W, Wang Z.   +9 more
europepmc   +1 more source